Evaluating the Use of Propranolol Monotherapy or Combined with Corticosteroids in the Treatment of Infantile Hemangioma
Mohamed Moussa Dahab Aly;
Abstract
benign tumor of infancy, present in 4% to 5% of the population.
The characteristic life cycle of IH makes it a unique childhood tumor. The biologic behavior of IH is subdivided into three phases, the first being a period of proliferation starting at 2–3
The characteristic life cycle of IH makes it a unique childhood tumor. The biologic behavior of IH is subdivided into three phases, the first being a period of proliferation starting at 2–3
Other data
| Title | Evaluating the Use of Propranolol Monotherapy or Combined with Corticosteroids in the Treatment of Infantile Hemangioma | Other Titles | تقييم استخدام البروبرانولول وحده أو مع الكورتيزون في علاج الوحمات الدموية للأطفال | Authors | Mohamed Moussa Dahab Aly | Keywords | Evaluating the Use of Propranolol Monotherapy or Combined with Corticosteroids in the Treatment of Infantile Hemangioma | Issue Date | 2013 | Description | benign tumor of infancy, present in 4% to 5% of the population. The characteristic life cycle of IH makes it a unique childhood tumor. The biologic behavior of IH is subdivided into three phases, the first being a period of proliferation starting at 2–3 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 118500a5298.pdf | 464.2 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.